SummaryTo compare the compliance with and tolerance of mefloquine ( M Q ) and chloroquine + proguanil (CQ-PRO) chemoprophylaxis, we conducted a study using a self-reported questionnaire i n 2 groups of native French adult visitors to Senegal or Kenya. C Q (TOO m g daily) + P R O (200 mg daily) prophylaxis was prescribed f o r all patients travelling to Senegal and for those going to Kenya when M Q was contraindicated; M Q (250 mg weekly) was prescribed for the other subjects. There were n o significant differences in age, sex, exposition and measures of protection against mosquito bites, concomitant drug use o r mean duration of chemoprophylaxis between the z groups, and compliance during travel was excellent in both. Chcmoprophylaxis w:is 11101-c frequently interrupted prematurely in the M Q group. T h e rates of overall sidc-effects attributed to malaria cheinoprophylaxis were 16% for M Q against 12% for CQ-PRO (not signihcant).However, nonserious neuropsychiatric adverse events are more frequent with MQ: I 1.5 "/ o compared to Z"/O with CQ-PRO. M Q should be used with caution.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.